Dyadic International (DYAI) EPS (Diluted) (2024 - 2026)
Powered by 
Analysis
Dyadic International (DYAI) EPS (Diluted) (2024 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.54 Bn | 192.56 Bn | 7.24 Bn | 4.37 |
| 2 | Gilead Sciences | 179.55 Bn | 176.37 Bn | 6.22 Bn | -8.44 |
| 3 | Vertex Pharmaceuticals | 131.10 Bn | 123.25 Bn | 2.84 Bn | 4.31 |
| 4 | Regeneron Pharmaceuticals | 81.61 Bn | 73.62 Bn | 3.93 Bn | 12.23 |
| 5 | Argenx Se | 60.69 Bn | 55.51 Bn | 1.37 Bn | 7.15 |
| 6 | Moderna | 53.54 Bn | 48.40 Bn | 52.00 Mn | -1.96 |
| 7 | Alnylam Pharmaceuticals | 33.41 Bn | 30.10 Bn | 992.69 Mn | 1.19 |
| 8 | Biogen | 31.80 Bn | 30.52 Bn | 1.96 Bn | 0.66 |
| 9 | Roivant Sciences | 29.08 Bn | 29.08 Bn | 1.16 Mn | -0.40 |
| 10 | Dyadic International | 18.46 Mn | 10.50 Mn | - | -0.05 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | -0.05 |
| Dec 31, 2025 | -0.05 |
| Sep 30, 2025 | -0.06 |
| Jun 30, 2025 | -0.06 |
| Mar 31, 2025 | -0.07 |
| Dec 31, 2024 | -0.05 |
| Sep 30, 2024 | -0.01 |
| Jun 30, 2024 | -0.07 |